SCHEDULE 13G/AAccepted Feb 6, 3:17 PM ET
Kyverna Therapeutics, Inc. SCHEDULE 13G/A
Accepted (ET)
3:17 PM
Feb 6, 2026
Filed
Feb 6, 2026
Documents
4
Size
47.2 KB
Summary
Summary not available
This filing does not have a written summary yet. You can still open the original filing and its exhibits.